A novel and highly efficient photocatalyst of a AgBiO3/BiOCl heterojunction has been developed via a facile water bath and in situ precipitation method. The photocatalytic activities of the catalysts were investigated by the degradation of ciprofloxacin (CIP) under visible-light irradiation (>420 nm). The experiment results revealed that the photocatalytic performance of the optimized AgBiO3/BiOCl heterojunction was much higher than pure AgBiO3 and BiOCl. The degradation efficiency of the as-prepared AgBiO3/BiOCl heterojunction (ABC-30) for CIP could reach 88% within 160 min, with 2.89 and 3.76 times higher activity than pure AgBiO3 and BiOCl, respectively. The improved photocatalytic performance of AgBiO3/BiOCl was attributed to the synergistic effect of the enhanced light absorption range and effective separation and transfer of the photo-induced charge carrier. The optimized heterojunction showed broad-spectrum catalytic activities towards various organic contaminants. The degradation efficiencies varied with the nature of the pollutant and decreased in the following order: Lanasol Red 5B (100%) > methyl orange (99%) > methylene blue (98%) > tetracycline (92%) > ciprofloxacin (88%) > ofloxacin (85%) > norfloxacin (78%) > rhodamine B (59%) > metronidazole (43%) > phenol (40%) > carbamazepine (20%). Furthermore, the trapping experiments and ESR indicated that superoxide radicals and holes were the main reactive species.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: